If you've stopped Ozempic, Wegovy, or Mounjaro and watched the weight slowly creep back — this article will probably frustrate you.
Not because of what you'll learn. Because of what your doctor never told you.
For the past three months, I've been investigating a phenomenon that's quietly affecting millions of GLP-1 patients across the United States: the post-medication rebound. The numbers are staggering.
According to a 2024 study published in Diabetes, Obesity and Metabolism, roughly two out of three patients regain most of their weight within 12 months of stopping GLP-1 medications. Not because they "let themselves go." Not because they stopped trying. But because of something happening inside their bodies that nobody warned them about.
I'll be transparent: I started this investigation skeptical. The supplement industry is full of "natural Ozempic alternatives" making increasingly absurd claims. I assumed any product specifically targeting post-GLP-1 patients would be more of the same.
Instead what I found changed my mind.